Strategene Gives Up Fight With Third Wave
The pair revealed the news on Tuesday, finally agreeing to bury the hatchet in their longstanding patent infringement litigation over the technology used in genetic testing.
"We're pleased to resolve this outstanding legal matter in a manner benefiting both companies," said Dr. Joseph A. Sorge, chairman and chief executive officer of Stratagene. “The...
Already a subscriber? Click here to login